Judith Haas

3.1k total citations
56 papers, 1.1k citations indexed

About

Judith Haas is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Judith Haas has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pathology and Forensic Medicine, 11 papers in Molecular Biology and 10 papers in Neurology. Recurrent topics in Judith Haas's work include Multiple Sclerosis Research Studies (36 papers), Peripheral Neuropathies and Disorders (8 papers) and Sphingolipid Metabolism and Signaling (8 papers). Judith Haas is often cited by papers focused on Multiple Sclerosis Research Studies (36 papers), Peripheral Neuropathies and Disorders (8 papers) and Sphingolipid Metabolism and Signaling (8 papers). Judith Haas collaborates with scholars based in Germany, United States and Austria. Judith Haas's co-authors include H.W.L. Ziegler-Heitbrock, G. Riethmüller, O. R. Hommes, Uwe K. Zettl, Patrick A. Baeuerle, Peter Flachenecker, Dieter Pöhlau, David Ellenberger, Alexander Stahmann and Paulus Rommer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Neurology.

In The Last Decade

Judith Haas

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith Haas Germany	19	577	333	221	216	170	56	1.1k
Carolina Ionete United States	16	495 0.9×	277 0.8×	151 0.7×	251 1.2×	491 2.9×	51	1.3k
Robert Heard Australia	21	414 0.7×	557 1.7×	268 1.2×	120 0.6×	242 1.4×	51	1.3k
Alexander Winkelmann Germany	15	585 1.0×	164 0.5×	156 0.7×	239 1.1×	137 0.8×	43	828
Robert Hoepner Switzerland	19	543 0.9×	169 0.5×	292 1.3×	324 1.5×	178 1.0×	96	1.1k
Christian Lechner Germany	21	320 0.6×	134 0.4×	209 0.9×	318 1.5×	356 2.1×	70	1.5k
Julius M. Cruse United States	22	268 0.5×	478 1.4×	190 0.9×	156 0.7×	182 1.1×	99	1.4k
Djaouïda Bengoufa France	20	327 0.6×	455 1.4×	148 0.7×	186 0.9×	207 1.2×	41	1.4k
Vincenzo Brescia Morra Italy	22	603 1.0×	78 0.2×	146 0.7×	283 1.3×	143 0.8×	76	1.2k
Gloria von Geldern United States	13	304 0.5×	124 0.4×	184 0.8×	214 1.0×	296 1.7×	32	994
Barbara Tucky United States	22	517 0.9×	809 2.4×	512 2.3×	182 0.8×	357 2.1×	29	2.1k

Countries citing papers authored by Judith Haas

Since Specialization

Citations

This map shows the geographic impact of Judith Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Haas more than expected).

Fields of papers citing papers by Judith Haas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Haas. The network helps show where Judith Haas may publish in the future.

Co-authorship network of co-authors of Judith Haas

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Haas. A scholar is included among the top collaborators of Judith Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Haas. Judith Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frahm, Niklas, David Ellenberger, Judith Haas, et al.. (2023). Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study. Journal of Clinical Medicine. 12(11). 3640–3640. 4 indexed citations

Frahm, Niklas, David Ellenberger, Judith Haas, et al.. (2023). Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study. Vaccines. 11(12). 1859–1859. 2 indexed citations

Staudacher, Erich M., et al.. (2023). Organization of descending neurons in the brain of the desert locust. The Journal of Comparative Neurology. 531(14). 1350–1380. 3 indexed citations

Frahm, Niklas, David Ellenberger, Judith Haas, et al.. (2022). SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study. The Lancet Regional Health - Europe. 22. 100502–100502. 17 indexed citations

Frahm, Niklas, David Ellenberger, Peter Flachenecker, et al.. (2022). Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry. Neurology and Therapy. 11(1). 319–336. 3 indexed citations

Ziemssen, Tjalf, Michael Lang, Stephan Schmidt, et al.. (2022). Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany. Journal of Neurology. 269(6). 3276–3285. 15 indexed citations

Frahm, Niklas, Jörg Bätzing, David Ellenberger, et al.. (2021). Prevalence of pediatric multiple sclerosis in Germany: A nationwide population‐based analysis. European Journal of Neurology. 28(9). 3173–3176. 6 indexed citations

Ellenberger, David, Peter Flachenecker, Tim Friede, et al.. (2021). Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry. Scientific Reports. 11(1). 13340–13340. 30 indexed citations

Frahm, Niklas, Jörg Bätzing, David Ellenberger, et al.. (2021). Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis. Therapeutic Advances in Neurological Disorders. 14. 4203329424–4203329424. 7 indexed citations

10.

Ziemssen, Tjalf, Judith Haas, Luisa Klotz, et al.. (2021). Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients. Frontiers in Neurology. 12. 637107–637107. 4 indexed citations

11.

Rauer, Sebastian, Muna‐Miriam Hoshi, Refik Pul, et al.. (2020). Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany. Clinical Neurology and Neurosurgery. 197. 106142–106142. 5 indexed citations

12.

Ohlmeier, Christoph, Holger Gothe, Judith Haas, et al.. (2020). Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data. PLoS ONE. 15(5). e0231846–e0231846. 23 indexed citations

13.

Ziemssen, Tjalf, Michael Lang, Björn Tackenberg, et al.. (2019). PANGAEA: Effectiveness and safety of fingolimod over 5 years in daily clinical practice (P3.2-086). Neurology. 92(15_supplement). 1 indexed citations

14.

Ziemssen, Tjalf, Achim Gass, Jens Wuerfel, et al.. (2016). Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab. BMC Neurology. 16(1). 98–98. 10 indexed citations

15.

Ziemssen, Tjalf, Judith Haas, Luisa Klotz, et al.. (2016). 4 Years Safety of Fingolimod in Real World: PANGAEA, a Non-Interventional Study of Safety, Effectiveness and Pharmacoeconomic Data for Fingolimod Patients in Daily Clinical Practice (P2.077). Neurology. 86(16_supplement). 1 indexed citations

16.

Haas, Judith. (2011). Pathophysiology, assessment and management of multiple sclerosis spasticity: an update. Expert Review of Neurotherapeutics. 11(sup4). 3–8. 14 indexed citations

17.

Ehrlich, Stefan, Judith Haas, Frauke Zipp, & Carmen Infante‐Duarte. (2006). Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy. Journal of the Neurological Sciences. 252(1). 83–87. 5 indexed citations

18.

Dörner, Thomas, Judith Haas, Christoph Loddenkemper, Hans‐Dieter Volk, & Abdulgabar Salama. (2006). Implant-related inflammatory arthritis. Nature Clinical Practice Rheumatology. 2(1). 53–56. 23 indexed citations

19.

Zipp, Frauke, Uwe Wendling, Martin K. Beyer, et al.. (2000). Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells. Journal of Neuroimmunology. 110(1-2). 214–222. 22 indexed citations

20.

Haas, Judith, G. Riethmüller, & H.W.L. Ziegler-Heitbrock. (1987). Monocyte Phenotype and Function in Patients with the Acquired Immunodeficiency Syndrome (AIDS) and AIDS‐Related Disorders. Scandinavian Journal of Immunology. 26(4). 371–379. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact